A Cluster Sequencing Strategy To Determine the Consensus Affinity Domains in Heparin for Its Binding to Specific Proteins.
暂无分享,去创建一个
R. Linhardt | Fuming Zhang | Tianji Zhang | Lan Jin | Anran Sheng | L. Chi | Hongmei Li | Changkai Bu | Zizhe An | Xiaojun Sun | Deling Shi | Xueying Cui | Lianli Chi | Fuming Zhang
[1] Joshua A. Klein,et al. GAGrank: Software for Glycosaminoglycan Sequence Ranking Using a Bipartite Graph Model , 2021, Molecular & cellular proteomics : MCP.
[2] R. Linhardt,et al. Design of anti-inflammatory heparan sulfate to protect against acetaminophen-induced acute liver failure , 2020, Science Translational Medicine.
[3] Xin Liu,et al. Oligosaccharides mapping of nitrous acid degraded heparin through UHPLC-HILIC/WAX-MS. , 2020, Carbohydrate polymers.
[4] Lan Jin,et al. The Role of Heparin/Heparan Sulphate in the IFN-γ-led Arena. , 2019, Biochimie.
[5] Xin Liu,et al. Characterization of epimerization and composition of heparin and dalteparin using a UHPLC-ESI-MS/MS method. , 2019, Carbohydrate polymers.
[6] T. Wight. A role for proteoglycans in vascular disease. , 2018, Matrix biology : journal of the International Society for Matrix Biology.
[7] L. Kjellén,et al. Specificity of glycosaminoglycan-protein interactions. , 2018, Current opinion in structural biology.
[8] R. Linhardt,et al. Sequencing the oligosaccharide pool in the low molecular weight heparin dalteparin with offline HPLC and ESI-MS/MS. , 2018, Carbohydrate polymers.
[9] R. Kozar,et al. Syndecan‐1 limits the progression of liver injury and promotes liver repair in acetaminophen‐induced liver injury in mice , 2017, Hepatology.
[10] R. Woods,et al. Synthesis of 3-O-Sulfated Oligosaccharides to Understand the Relationship between Structures and Functions of Heparan Sulfate. , 2017, Journal of the American Chemical Society.
[11] M. Ishihara,et al. Integrated Approach to Identify Heparan Sulfate Ligand Requirements of Robo1. , 2016, Journal of the American Chemical Society.
[12] Roger L. Williams,et al. The US regulatory and pharmacopeia response to the global heparin contamination crisis , 2016, Nature Biotechnology.
[13] R. Linhardt,et al. Comparison of Low-Molecular-Weight Heparins Prepared From Bovine Lung Heparin and Porcine Intestine Heparin. , 2016, Journal of pharmaceutical sciences.
[14] W. Weitschies,et al. Binding of anti-platelet factor 4/heparin antibodies depends on the thermodynamics of conformational changes in platelet factor 4. , 2014, Blood.
[15] G. Torri,et al. Antithrombin-binding oligosaccharides: structural diversities in a unique function? , 2014, Glycoconjugate Journal.
[16] A. Imberty,et al. Insights into the mechanism by which interferon-γ basic amino acid clusters mediate protein binding to heparan sulfate. , 2013, Journal of the American Chemical Society.
[17] Robert J Linhardt,et al. Top-down approach for the direct characterization of low molecular weight heparins using LC-FT-MS. , 2012, Analytical Chemistry.
[18] R. Linhardt,et al. Complete mass spectral characterization of a synthetic ultralow-molecular-weight heparin using collision-induced dissociation. , 2012, Analytical chemistry.
[19] M. Nugent,et al. A Computational Approach for Deciphering the Organization of Glycosaminoglycans , 2010, PloS one.
[20] J. Leary,et al. Heparin sequencing using enzymatic digestion and ESI-MSn with HOST: a heparin/HS oligosaccharide sequencing tool. , 2005, Analytical chemistry.
[21] R. Linhardt,et al. Heparin-protein interactions. , 2002, Angewandte Chemie.
[22] Z. Shriver,et al. Sequencing complex polysaccharides. , 1999, Science.
[23] H. Lortat-Jacob,et al. The Heparan Sulfate Binding Sequence of Interferon-γ Increased the On Rate of the Interferon-γ-Interferon-γ Receptor Complex Formation* , 1998, The Journal of Biological Chemistry.
[24] A. Shvartsburg,et al. An exact hard-spheres scattering model for the mobilities of polyatomic ions , 1996 .
[25] George C. Schatz,et al. Structural Information from Ion Mobility Measurements: Effects of the Long-Range Potential , 1996 .